DeCensi A - Search Results

1

18F-FDG PET/CT is a prognostic biomarker in patients affected by bone metastases from breast cancer in comparison with 18F-NaF PET/CT.

Piccardo A, Puntoni M, Morbelli S, Massollo M, Bongioanni F, Paparo F, Altrinetti V, Gonella R, Gennari A, Iacozzi M, Sambuceti G, DeCensi A. Piccardo A, et al. Among authors: decensi a. Nuklearmedizin. 2015;54(4):163-72. doi: 10.3413/Nukmed-0727-15-02. Epub 2015 Jul 13. Nuklearmedizin. 2015. PMID: 26165806

2

Clinical trials with retinoids for breast cancer chemoprevention.

Zanardi S, Serrano D, Argusti A, Barile M, Puntoni M, Decensi A. Zanardi S, et al. Among authors: decensi a. Endocr Relat Cancer. 2006 Mar;13(1):51-68. doi: 10.1677/erc.1.00938. Endocr Relat Cancer. 2006. PMID: 16601279 Review.

3

Prognostic effect of DNA aneuploidy from bladder washings in superficial bladder cancer.

Puntoni M, Zanardi S, Branchi D, Bruno S, Curotto A, Varaldo M, Bruzzi P, Decensi A. Puntoni M, et al. Among authors: decensi a. Cancer Epidemiol Biomarkers Prev. 2007 May;16(5):979-83. doi: 10.1158/1055-9965.EPI-06-0538. Cancer Epidemiol Biomarkers Prev. 2007. PMID: 17507625

4

Psychological and clinical factors implicated in decision making about a trial of low-dose tamoxifen in hormone replacement therapy users.

Rondanina G, Puntoni M, Severi G, Varricchio C, Zunino A, Feroce I, Bonanni B, Decensi A. Rondanina G, et al. Among authors: decensi a. J Clin Oncol. 2008 Mar 20;26(9):1537-43. doi: 10.1200/JCO.2007.13.6739. J Clin Oncol. 2008. PMID: 18349406

5

Inflammation and cancer prevention.

Puntoni M, Marra D, Zanardi S, Decensi A. Puntoni M, et al. Among authors: decensi a. Ann Oncol. 2008 Sep;19 Suppl 7:vii225-9. doi: 10.1093/annonc/mdn442. Ann Oncol. 2008. PMID: 18790956 Free article. Review. No abstract available.

6

Dietary changes after breast cancer in women without hot flashes: a simple and inexpensive way to target tumor and host?

Puntoni M, Bonanni B, Decensi A. Puntoni M, et al. Among authors: decensi a. J Clin Oncol. 2009 Jan 20;27(3):323-5. doi: 10.1200/JCO.2008.19.7764. Epub 2008 Dec 15. J Clin Oncol. 2009. PMID: 19075255 No abstract available.

7

The rationale and potential of cancer chemoprevention with special emphasis on breast cancer.

Puntoni M, Decensi A. Puntoni M, et al. Among authors: decensi a. Eur J Cancer. 2009 Sep;45 Suppl 1:346-54. doi: 10.1016/S0959-8049(09)70049-8. Eur J Cancer. 2009. PMID: 19775631 Review. No abstract available.

8

Metformin and cancer risk in diabetic patients: a systematic review and meta-analysis.

Decensi A, Puntoni M, Goodwin P, Cazzaniga M, Gennari A, Bonanni B, Gandini S. Decensi A, et al. Cancer Prev Res (Phila). 2010 Nov;3(11):1451-61. doi: 10.1158/1940-6207.CAPR-10-0157. Epub 2010 Oct 12. Cancer Prev Res (Phila). 2010. PMID: 20947488 Review.

9

Insulin breast cancer connection: confirmatory data set the stage for better care.

DeCensi A, Gennari A. DeCensi A, et al. J Clin Oncol. 2011 Jan 1;29(1):7-10. doi: 10.1200/JCO.2010.32.3022. Epub 2010 Nov 29. J Clin Oncol. 2011. PMID: 21115871 No abstract available.

10

Duration of chemotherapy for metastatic breast cancer: a systematic review and meta-analysis of randomized clinical trials.

Gennari A, Stockler M, Puntoni M, Sormani M, Nanni O, Amadori D, Wilcken N, D'Amico M, DeCensi A, Bruzzi P. Gennari A, et al. Among authors: decensi a. J Clin Oncol. 2011 Jun 1;29(16):2144-9. doi: 10.1200/JCO.2010.31.5374. Epub 2011 Apr 4. J Clin Oncol. 2011. PMID: 21464403 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

274 results

Search Page

Filters